发明名称 N1/N2-lactam acetyl-CoA carboxylase inhibitors
摘要 The invention provides a compound of Formula (I); or a pharmaceutically acceptable salt thereof; wherein G is ; R1, R2 and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
申请公布号 US8859773(B2) 申请公布日期 2014.10.14
申请号 US201113282964 申请日期 2011.10.27
申请人 Pfizer Inc. 发明人 Griffith David A.;Dow Robert L.;Bagley Scott W.;Smith Aaron
分类号 C07D471/20;C07D519/00;A61K31/4725 主分类号 C07D471/20
代理机构 代理人 Wasicak James T.
主权项 1. A compound of structure or a pharmaceutically acceptable salt thereof.
地址 New York NY US